The 2013 NCCN Case Manager Webinar Series will consist of six live webinars on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

The 2013 NCCN Case Manager Webinar Series will consist of six live webinars on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

The 2013 NCCN Case Manager Webinar Series will consist of six live webinars on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

The 2013 NCCN Case Manager Webinar Series will consist of six live webinars on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

Join Jeffrey M. Farma, MD (Surgeon) and Anthony J. Olszanski, MD, RPh (Medical Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to melanoma.

Presented by Dr. Azeez Farooki, this live webinar will discuss report findings from a recent task force of key experts that NCCN assembled to identify and address important clinical issues with regards to treatment management of bone health in cancer care.

Join Al B. Benson III, MD (Medical Oncologist) and William Small, Jr., MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to colon cancer.

Join Jeffrey Bradley, MD (Radiation Oncology), Ramaswamy Govindan, MD (Medical Oncology), and Peter Humphrey, MD, PhD (Surgical Pathology) as they present their multidisciplinary expertise on a range of cases pertaining to advanced adenocarcinoma.

Biomarkers now play a key role in the routine management of patients with cancer and guide drug development in the age of targeted therapy.

Join Harold Burstein, MD, PhD (Medical Oncologist) and Jennifer Bellon, MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to triple negative breast cancer.